Neuromeka (348340.KQ) Earnings Analysis

Neuromeka (348340.KQ) has no confirmed upcoming earnings date. Trailing P/E -8.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 348340.KQ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 348340.KQ. This page updates as the calendar is published.

348340.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-12-505.23 KRWn/an/an/a
2025-11-14-377 KRWn/an/an/a
2025-08-14-438.17 KRWn/an/an/a
2025-05-15-693.04 KRWn/an/an/a
2025-03-13-381.89 KRWn/an/an/a
2024-11-14-643 KRWn/an/an/a
2024-08-19-22 KRWn/an/an/a

348340.KQ valuation and analyst view

Trailing P/E-8.55
Trailing EPS-3,309.49382 KRW
Price / book8.83
Dividend yield0.00%
Market cap396.46B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Neuromeka (348340.KQ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 348340.KQ. This page updates as the calendar is published.

Did 348340.KQ beat earnings last quarter?

Consensus estimate data was not available for 348340.KQ's 2026-03-12 report.

What is 348340.KQ's current P/E ratio and EPS?

348340.KQ trades at a trailing P/E of -8.55 on trailing EPS of -3309.4938247032906 KRW.

What do analysts rate 348340.KQ?

348340.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.